2-(3-Methoxy-4-(4-methyl-1H-imidazol-1-yl)phenylamino)-6-((2,2,2-trifluoroethoxy)methyl)-pyrimidine-4-carbaldehyde → Cyclopropyl(2-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenylamino)-6-((2,2,2-trifluoroethoxy)methyl)pyrimidin-4-yl)methanol
Reaction equation
[CH:1]1([Mg]Br)[CH2:3][CH2:2]1.[CH3:6][O:7][C:8]1[CH:9]=[C:10]([NH:20][C:21]2[N:26]=[C:25]([CH:27]=[O:28])[CH:24]=[C:23]([CH2:29][O:30][CH2:31][C:32]([F:35])([F:34])[F:33])[N:22]=2)[CH:11]=[CH:12][C:13]=1[N:14]1[CH:18]=[C:17]([CH3:19])[N:16]=[CH:15]1>C1COCC1>[CH:1]1([CH:27]([C:25]2[CH:24]=[C:23]([CH2:29][O:30][CH2:31][C:32]([F:33])([F:35])[F:34])[N:22]=[C:21]([NH:20][C:10]3[CH:11]=[CH:12][C:13]([N:14]4[CH:18]=[C:17]([CH3:19])[N:16]=[CH:15]4)=[C:8]([O:7][CH3:6])[CH:9]=3)[N:26]=2)[OH:28])[CH2:3][CH2:2]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To an ice-cold solution of cyclopropylmagnesium bromide (1.90 mL, 0.95 mmol) in THF (10 mL), a solution of 2-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenylamino)-6-((2,2,2-trifluoroethoxy)methyl)pyrimidine-4-carbaldehyde (40 mg, 0.09 mmol) in THF (6 mL) was added over 5 min. The mixture was stirred on ice-bath for 30 minutes before it was quenched with ammonium chloride (aq, sat). The solvent volume was reduced by evaporation. The mixture was extracted with dichloromethane, the organic phase was passed through a phase separator and concentrated in vacuum. The residue was purified by preparative HPLC to give the title compound as a dry film, 7 mg (16%).
Workup
- customwas quenched with ammonium chloride (aq, sat)
- customThe solvent volume was reduced by evaporation
- extractionThe mixture was extracted with dichloromethane
- concentrationconcentrated in vacuum
- customThe residue was purified by preparative HPLC
Sources & evidence
- ORD record
- ord-f0147134e4364c48bd4999c5edf3e11c
- Source dataset
- uspto-grants-2016_09
- Patent number
- US09439904B2
Reaction notes
Loading…